<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37516812</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Assessing causal relationship between circulating cytokines and age-related neurodegenerative diseases: a bidirectional two-sample Mendelian randomization analysis.</ArticleTitle><Pagination><StartPage>12325</StartPage><MedlinePgn>12325</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12325</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-39520-9</ELocationID><Abstract><AbstractText>Numerous studies have reported that circulating cytokines (CCs) are linked to age-related neurodegenerative diseases (ANDDs); however, there is a lack of systematic investigation for the causal association. A two-sample bidirectional Mendelian Randomisation (MR) method was utilized to evaluate the causal effect. We applied genetic variants correlated with concentrations of CCs from a genome-wide association study meta-analysis (n&#x2009;=&#x2009;8293) as instrumental variables. Summary data of three major ANDDs [Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic lateral sclerosis (ALS)] were identified from the IEU OpenGWAS platform (n&#x2009;=&#x2009;627, 266). Inverse-variance weighted method is the main approach to analyse causal effect, and MR results are verified by several sensitivity and pleiotropy analyses. In directional MR, it suggested that several CCs were nominally correlated with the risk of ANDDs, with a causal odds ratio (OR) of Interleukin (IL)-5 of 0.909 for AD; OR of IL-2 of 1.169 for PD; and OR of Beta nerve growth factor of 1.142 for ALS). In reverse MR, there were some suggestively causal effects of ANDDs on CCs (AD on increased Basic fibroblast growth factor and IL-12 and decreased Stem cell growth factor beta; PD on decreased Monokine induced by interferon-gamma; ALS on decreased Basic fibroblast growth factor and IL-17). The findings were stable across sensitivity and pleiotropy analyses. However, after Bonferroni correction, there is no statistically significant association between CCs and ANDDs. Through the genetic epidemiological approach, our study assessed the role and presented possible causal associations between CCs and ANDDs. Further studies are warranted to verify the causal associations.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yin</LastName><ForeName>Zihan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Manze</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xinyue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yaqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhenghong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Qiongnan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Wanqi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Kexin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China. zhaoling@cdutcm.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China. zhaoling@cdutcm.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Fanrong</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Acu-Mox and Tuina, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, 610075, Sichuan, China. acuresearch@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acupuncture Clinical Research Center of Sichuan Province, Chengdu, China. acuresearch@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>103107-01-3</RegistryNumber><NameOfSubstance UI="D016222">Fibroblast Growth Factor 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016222" MajorTopicYN="N">Fibroblast Growth Factor 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37516812</ArticleId><ArticleId IdType="pmc">PMC10387057</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-39520-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-39520-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heemels MT. Neurodegenerative diseases. Nature. 2016;539(7628):179. doi: 10.1038/539179a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/539179a</ArticleId><ArticleId IdType="pubmed">27830810</ArticleId></ArticleIdList></Reference><Reference><Citation>Berson A, Nativio R, Berger SL, Bonini NM. Epigenetic regulation in neurodegenerative diseases. Trends Neurosci. 2018;41(9):587&#x2013;598. doi: 10.1016/j.tins.2018.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.05.005</ArticleId><ArticleId IdType="pmc">PMC6174532</ArticleId><ArticleId IdType="pubmed">29885742</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbito A, Dulewicz M, Kulczy&#x144;ska-Przybik A, Mroczko B. Biochemical markers in Alzheimer&#x2019;s disease. Int. J. Mol. Sci. 2020;21(6):1989. doi: 10.3390/ijms21061989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21061989</ArticleId><ArticleId IdType="pmc">PMC7139967</ArticleId><ArticleId IdType="pubmed">32183332</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaugler J, et al. 2022 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement. 2022;18(4):700&#x2013;789. doi: 10.1002/alz.12638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12638</ArticleId><ArticleId IdType="pubmed">35289055</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut P, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson&#x2019;s disease. Prog. Neurobiol. 2015;132:96&#x2013;168. doi: 10.1016/j.pneurobio.2015.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2015.07.002</ArticleId><ArticleId IdType="pubmed">26209473</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo A, Monteiro L, Lima RM, Oliveira DM, Cerqueira MD, El-Bach&#xe1; RS. Oxidative stress in neurodegenerative diseases: Mechanisms and therapeutic perspectives. Oxid. Med. Cell. Longev. 2011;2011:467180. doi: 10.1155/2011/467180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/467180</ArticleId><ArticleId IdType="pmc">PMC3236428</ArticleId><ArticleId IdType="pubmed">22191013</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, Zhan S, Wang S. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. 2020;267(4):944&#x2013;953. doi: 10.1007/s00415-019-09652-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Chen L, Wang S, Feng J, Liu L, Liu G, Wang J, Zhan S, Gao P, Fan D. Incidence and prevalence of amyotrophic lateral sclerosis in urban China: A national population-based study. J. Neurol. Neurosurg. Psychiatry. 2020;91(5):520&#x2013;525. doi: 10.1136/jnnp-2019-322317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322317</ArticleId><ArticleId IdType="pubmed">32139654</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Liu C. Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases. Nat. Rev. Neurosci. 2022;23(9):523&#x2013;534. doi: 10.1038/s41583-022-00603-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-022-00603-7</ArticleId><ArticleId IdType="pubmed">35637417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O. Biomarkers for neurodegenerative diseases. Nat. Med. 2021 doi: 10.1038/s41591-021-01382-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01382-x</ArticleId><ArticleId IdType="pubmed">34083813</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 2017;9(7):a028035. doi: 10.1101/cshperspect.a028035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028035</ArticleId><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson J, Nutma E, van der Valk P, Amor S. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154(2):204&#x2013;219. doi: 10.1111/imm.12922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12922</ArticleId><ArticleId IdType="pmc">PMC5980185</ArticleId><ArticleId IdType="pubmed">29513402</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer&#x2019;s disease. J. Neuroinflamm. 2022;19(1):206. doi: 10.1186/s12974-022-02565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02565-0</ArticleId><ArticleId IdType="pmc">PMC9382837</ArticleId><ArticleId IdType="pubmed">35978311</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinn H, Tatton N, McCaughey S, Kurnellas M, Rosenthal A. Progranulin as a therapeutic target in neurodegenerative diseases. Trends Pharmacol. Sci. 2022;43(8):641&#x2013;652. doi: 10.1016/j.tips.2021.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2021.11.015</ArticleId><ArticleId IdType="pubmed">35039149</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivandzade F, Cucullo L. Regenerative stem cell therapy for neurodegenerative diseases: An overview. Int. J. Mol. Sci. 2021;22(4):2153. doi: 10.3390/ijms22042153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22042153</ArticleId><ArticleId IdType="pmc">PMC7926761</ArticleId><ArticleId IdType="pubmed">33671500</ArticleId></ArticleIdList></Reference><Reference><Citation>Subhramanyam CS, Wang C, Hu Q, Dheen ST. Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin. Cell Dev. Biol. 2019;94:112&#x2013;120. doi: 10.1016/j.semcdb.2019.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.004</ArticleId><ArticleId IdType="pubmed">31077796</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltazar MT, Dinis-Oliveira RJ, de Lourdes BM, Tsatsakis AM, Duarte JA, Carvalho F. Pesticides exposure as etiological factors of Parkinson&#x2019;s disease and other neurodegenerative diseases: A mechanistic approach. Toxicol. Lett. 2014;230(2):85&#x2013;103. doi: 10.1016/j.toxlet.2014.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2014.01.039</ArticleId><ArticleId IdType="pubmed">24503016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortada I, Farah R, Nabha S, Ojcius DM, Fares Y, Almawi WY, Sadier NS. Immunotherapies for neurodegenerative diseases. Front. Neurol. 2021;12:654739. doi: 10.3389/fneur.2021.654739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.654739</ArticleId><ArticleId IdType="pmc">PMC8215715</ArticleId><ArticleId IdType="pubmed">34163421</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi N, Stoner L, Farajivafa V, Hanson ED. Exercise training, circulating cytokine levels and immune function in cancer survivors: A meta-analysis. Brain Behav. Immun. 2019;81:92&#x2013;104. doi: 10.1016/j.bbi.2019.08.187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.08.187</ArticleId><ArticleId IdType="pubmed">31454519</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SY, Lee JH, Gide TN, Menzies AM, Guminski A, Carlino MS, Breen EJ, Yang J, Ghazanfar S, Kefford RF, et al. Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1-based immunotherapy. Clin. Cancer Res. 2019;25(5):1557&#x2013;1563. doi: 10.1158/1078-0432.CCR-18-2795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-18-2795</ArticleId><ArticleId IdType="pubmed">30409824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendorius M, Po C, Muller S, Jeltsch-David H. From systemic inflammation to neuroinflammation: The case of neurolupus. Int. J. Mol. Sci. 2018;19(11):3588. doi: 10.3390/ijms19113588.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19113588</ArticleId><ArticleId IdType="pmc">PMC6274746</ArticleId><ArticleId IdType="pubmed">30428632</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eldik LJ, Thompson WL, Ralay RH, Behanna HA, Martin WD. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: Function-based and target-based discovery approaches. Int. Rev. Neurobiol. 2007;82:277&#x2013;296. doi: 10.1016/S0074-7742(07)82015-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0074-7742(07)82015-0</ArticleId><ArticleId IdType="pubmed">17678967</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatino JJ, Pr&#xf6;bstel AK, Zamvil SS. B cells in autoimmune and neurodegenerative central nervous system diseases. Nat. Rev. Neurosci. 2019;20(12):728&#x2013;745. doi: 10.1038/s41583-019-0233-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0233-2</ArticleId><ArticleId IdType="pubmed">31712781</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsay RM. Neurotrophic growth factors and neurodegenerative diseases: Therapeutic potential of the neurotrophins and ciliary neurotrophic factor. Neurobiol. Aging. 1994;15(2):249&#x2013;251. doi: 10.1016/0197-4580(94)90124-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-4580(94)90124-4</ArticleId><ArticleId IdType="pubmed">7838303</ArticleId></ArticleIdList></Reference><Reference><Citation>Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925&#x2013;1926. doi: 10.1001/jama.2017.17219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.17219</ArticleId><ArticleId IdType="pubmed">29164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat. Med. 2008;27(8):1133&#x2013;1163. doi: 10.1002/sim.3034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3034</ArticleId><ArticleId IdType="pubmed">17886233</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova VW, Richmond RC, Woolf B, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins J, Timpson NJ, Dimou N, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement. JAMA. 2021;326(16):1614&#x2013;1621. doi: 10.1001/jama.2021.18236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.18236</ArticleId><ArticleId IdType="pubmed">34698778</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova VW, Richmond RC, Woolf B, Davies NM, Swanson SA, VanderWeele TJ, Timpson NJ, Higgins J, Dimou N, Langenberg C, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): Explanation and elaboration. BMJ. 2021;375:n2233. doi: 10.1136/bmj.n2233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2233</ArticleId><ArticleId IdType="pmc">PMC8546498</ArticleId><ArticleId IdType="pubmed">34702754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahola-Olli AV, W&#xfc;rtz P, Havulinna AS, Aalto K, Pitk&#xe4;nen N, Lehtim&#xe4;ki T, K&#xe4;h&#xf6;nen M, Lyytik&#xe4;inen LP, Raitoharju E, Sepp&#xe4;l&#xe4; I, et al. Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors. Am. J. Hum. Genet. 2017;100(1):40&#x2013;50. doi: 10.1016/j.ajhg.2016.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.11.007</ArticleId><ArticleId IdType="pmc">PMC5223028</ArticleId><ArticleId IdType="pubmed">27989323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates A&#x3b2;, tau, immunity and lipid processing. Nat. Genet. 2019;51(3):414&#x2013;430. doi: 10.1038/s41588-019-0358-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0358-2</ArticleId><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: A meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18(12):1091&#x2013;1102. doi: 10.1016/S1474-4422(19)30320-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30320-5</ArticleId><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97(6):1268&#x2013;1283. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Deng M, Lin Y, Gao W, Liu B, Xia H. Genetically predicted circulating levels of glycine, glutamate, and serotonin in relation to the risks of three major neurodegenerative diseases: A Mendelian randomization analysis. Front. Aging Neurosci. 2022;14:938408. doi: 10.3389/fnagi.2022.938408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.938408</ArticleId><ArticleId IdType="pmc">PMC9490425</ArticleId><ArticleId IdType="pubmed">36158554</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui G, Li S, Ye H, Yang Y, Huang Q, Chu Y, Shi Z, Zhang X. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study. Front. Immunol. 2022;13:956005. doi: 10.3389/fimmu.2022.956005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.956005</ArticleId><ArticleId IdType="pmc">PMC9493012</ArticleId><ArticleId IdType="pubmed">36159838</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullell N, C&#xe1;rcel-M&#xe1;rquez J, Gallego-F&#xe1;brega C, Mui&#xf1;o E, Lluci&#xe0;-Carol L, Lled&#xf3;s M, Amaut K, Krupinski J, Fern&#xe1;ndez-Cadenas I. Sleep/wake cycle alterations as a cause of neurodegenerative diseases: A Mendelian randomization study. Neurobiol. Aging. 2021;106:320&#x2013;321. doi: 10.1016/j.neurobiolaging.2021.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.05.008</ArticleId><ArticleId IdType="pubmed">34130902</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi M, Zhao W, Fei Q, Tan Y, Liu K, Chen Z, Zhang Y. Causal analysis between altered levels of interleukins and obstructive sleep apnea. Front Immunol. 2022;13:888644. doi: 10.3389/fimmu.2022.888644.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.888644</ArticleId><ArticleId IdType="pmc">PMC9363575</ArticleId><ArticleId IdType="pubmed">35967324</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol. 2011;40(3):740&#x2013;752. doi: 10.1093/ije/dyq151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyq151</ArticleId><ArticleId IdType="pmc">PMC3147064</ArticleId><ArticleId IdType="pubmed">20813862</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 2013;37(7):658&#x2013;665. doi: 10.1002/gepi.21758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21758</ArticleId><ArticleId IdType="pmc">PMC4377079</ArticleId><ArticleId IdType="pubmed">24114802</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Zhang H, Yu K. Power calculation for the general two-sample Mendelian randomization analysis. Genet. Epidemiol. 2020;44(3):290&#x2013;299. doi: 10.1002/gepi.22284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.22284</ArticleId><ArticleId IdType="pmc">PMC8766247</ArticleId><ArticleId IdType="pubmed">32048336</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int. J. Epidemiol. 2014;43(3):922&#x2013;929. doi: 10.1093/ije/dyu005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu005</ArticleId><ArticleId IdType="pmc">PMC4052137</ArticleId><ArticleId IdType="pubmed">24608958</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Fang T, Lv Y. Causal associations between thyroid dysfunction and COVID-19 susceptibility and severity: A bidirectional Mendelian randomization study. Front. Endocrinol. (Lausanne) 2022;13:961717. doi: 10.3389/fendo.2022.961717.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.961717</ArticleId><ArticleId IdType="pmc">PMC9485491</ArticleId><ArticleId IdType="pubmed">36147565</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Huang Y, Hu J, Shao Z. Mendelian randomization study of inflammatory bowel disease and bone mineral density. BMC Med. 2020;18(1):312. doi: 10.1186/s12916-020-01778-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01778-5</ArticleId><ArticleId IdType="pmc">PMC7654011</ArticleId><ArticleId IdType="pubmed">33167994</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottigliengo D, Foco L, Seibler P, Klein C, K&#xf6;nig IR, Del GMF. A Mendelian randomization study investigating the causal role of inflammation on Parkinson&#x2019;s disease. Brain. 2022;145(10):3444&#x2013;3453. doi: 10.1093/brain/awac193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac193</ArticleId><ArticleId IdType="pmc">PMC9586538</ArticleId><ArticleId IdType="pubmed">35656776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagoni P, Korologou-Linden RS, Howe LD, Davey SG, Ben-Shlomo Y, Stergiakouli E, Anderson EL. Causal effects of circulating cytokine concentrations on risk of Alzheimer&#x2019;s disease and cognitive function. Brain Behav. Immun. 2022;104:54&#x2013;64. doi: 10.1016/j.bbi.2022.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.05.006</ArticleId><ArticleId IdType="pmc">PMC10391322</ArticleId><ArticleId IdType="pubmed">35580794</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung C, Schooling CM. Systemic inflammatory regulators and risk of Alzheimer&#x2019;s disease: A bidirectional Mendelian-randomization study. Int. J. Epidemiol. 2021;50(3):829&#x2013;840. doi: 10.1093/ije/dyaa241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa241</ArticleId><ArticleId IdType="pubmed">33313759</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S, Roos PM, Larsson SC. Interleukin-1 receptor antagonist, interleukin-2 receptor alpha subunit and amyotrophic lateral sclerosis. Eur. J. Neurol. 2020;27(10):1913&#x2013;1917. doi: 10.1111/ene.14338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14338</ArticleId><ArticleId IdType="pubmed">32441415</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Zhang X, Guo N, Tian D, Zhang C, Mu C, Han C, Zhu R, Zhang J, Liu X. Genetically predicted levels of circulating inflammatory cytokines and the risk and age at onset of Parkinson&#x2019;s disease: A two-sample Mendelian randomization study. Front. Aging Neurosci. 2022;14:811059. doi: 10.3389/fnagi.2022.811059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.811059</ArticleId><ArticleId IdType="pmc">PMC8923644</ArticleId><ArticleId IdType="pubmed">35299944</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsui A, Davis D. Systemic inflammation and causal risk for Alzheimer&#x2019;s dementia: Possibilities and limitations of a Mendelian randomization approach. Aging Med. (Milton) 2018;1(3):249&#x2013;253. doi: 10.1002/agm2.12046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/agm2.12046</ArticleId><ArticleId IdType="pmc">PMC6640034</ArticleId><ArticleId IdType="pubmed">31328178</ArticleId></ArticleIdList></Reference><Reference><Citation>Richartz E, Stransky E, Batra A, Simon P, Lewczuk P, Buchkremer G, Bartels M, Schott K. Decline of immune responsiveness: A pathogenetic factor in Alzheimer&#x2019;s disease? J. Psychiatr. Res. 2005;39(5):535&#x2013;543. doi: 10.1016/j.jpsychires.2004.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2004.12.005</ArticleId><ArticleId IdType="pubmed">15992563</ArticleId></ArticleIdList></Reference><Reference><Citation>Merriwether EN, Agalave NM, Dailey DL, Rakel BA, Kolker SJ, Lenert ME, Spagnola WH, Lu Y, Geasland KM, Allen LH, et al. IL-5 mediates monocyte phenotype and pain outcomes in fibromyalgia. Pain. 2021;162(5):1468&#x2013;1482. doi: 10.1097/j.pain.0000000000002089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002089</ArticleId><ArticleId IdType="pmc">PMC7987864</ArticleId><ArticleId IdType="pubmed">33003107</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagase H, Ueki S, Fujieda S. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergol. Int. 2020;69(2):178&#x2013;186. doi: 10.1016/j.alit.2020.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2020.02.002</ArticleId><ArticleId IdType="pubmed">32139163</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood LB, Winslow AR, Proctor EA, McGuone D, Mordes DA, Frosch MP, Hyman BT, Lauffenburger DA, Haigis KM. Identification of neurotoxic cytokines by profiling Alzheimer&#x2019;s disease tissues and neuron culture viability screening. Sci. Rep. 2015;5:16622. doi: 10.1038/srep16622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16622</ArticleId><ArticleId IdType="pmc">PMC4643219</ArticleId><ArticleId IdType="pubmed">26564777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez AF, Hercus TR, Ekert P, Littler DR, Guthridge M, Thomas D, Ramshaw HS, Stomski F, Perugini M, D'Andrea R, et al. Molecular basis of cytokine receptor activation. IUBMB Life. 2010;62(7):509&#x2013;518. doi: 10.1002/iub.350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.350</ArticleId><ArticleId IdType="pubmed">20540154</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung I, Sankar P, Zhang Y, Robison LS, Zhao X, D'Souza SS, Salinero AE, Wang Y, Qian J, Kuentzel ML, et al. Activation of group 2 innate lymphoid cells alleviates aging-associated cognitive decline. J Exp. Med. 2020 doi: 10.1084/jem.20190915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190915</ArticleId><ArticleId IdType="pmc">PMC7144523</ArticleId><ArticleId IdType="pubmed">32022838</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennakoon A, Katharesan V, Musgrave IF, Koblar SA, Faull R, Curtis MA, Johnson IP. Normal aging, motor neurone disease, and Alzheimer&#x2019;s disease are characterized by cortical changes in inflammatory cytokines. J. Neurosci. Res. 2022;100(2):653&#x2013;669. doi: 10.1002/jnr.24996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24996</ArticleId><ArticleId IdType="pubmed">34882833</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung I, Zhang Y, Shin DS, Sankar P, Sun X, D'Souza SS, Song R, Kuentzel ML, Chittur SV, Zuloaga KL, et al. Group 2 innate lymphoid cells are numerically and functionally deficient in the triple transgenic mouse model of Alzheimer&#x2019;s disease. J. Neuroinflamm. 2021;18(1):152. doi: 10.1186/s12974-021-02202-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02202-2</ArticleId><ArticleId IdType="pmc">PMC8261980</ArticleId><ArticleId IdType="pubmed">34229727</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Rombos A, Tsoutsou A, Vassilopoulos DD. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer&#x2019;s disease and frontotemporal dementia. J. Neurol. Sci. 2006;249(2):110&#x2013;114. doi: 10.1016/j.jns.2006.05.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.05.063</ArticleId><ArticleId IdType="pubmed">16843497</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan MS, Yu JT, Jiang T, Zhu XC, Guan HS, Tan L. IL12/23 p40 inhibition ameliorates Alzheimer&#x2019;s disease-associated neuropathology and spatial memory in SAMP8 mice. J. Alzheimers Dis. 2014;38(3):633&#x2013;646. doi: 10.3233/JAD-131148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-131148</ArticleId><ArticleId IdType="pubmed">24047617</ArticleId></ArticleIdList></Reference><Reference><Citation>Vom BJ, Prokop S, Miller KR, Obst J, K&#xe4;lin RE, Lopategui-Cabezas I, Wegner A, Mair F, Schipke CG, Peters O, et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer&#x2019;s disease-like pathology and cognitive decline. Nat. Med. 2012;18(12):1812&#x2013;1819. doi: 10.1038/nm.2965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2965</ArticleId><ArticleId IdType="pubmed">23178247</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C, Zhao K, Xia H, Xu Y. Peripheral inflammatory biomarkers in Alzheimer&#x2019;s disease and mild cognitive impairment: A systematic review and meta-analysis. Psychogeriatrics. 2019;19(4):300&#x2013;309. doi: 10.1111/psyg.12403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12403</ArticleId><ArticleId IdType="pubmed">30790387</ArticleId></ArticleIdList></Reference><Reference><Citation>Magalh&#xe3;es T, Weiler M, Teixeira C, Hayata T, Moraes AS, Boldrini VO, Dos SL, de Campos BM, de Rezende T, Joaquim H, et al. Systemic inflammation and multimodal biomarkers in amnestic mild cognitive impairment and Alzheimer&#x2019;s disease. Mol. Neurobiol. 2018;55(7):5689&#x2013;5697. doi: 10.1007/s12035-017-0795-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0795-9</ArticleId><ArticleId IdType="pubmed">29039020</ArticleId></ArticleIdList></Reference><Reference><Citation>Orozco VA, Camargo KM, Suavinho FE, Antonio SM. Interleukin-2 as immunotherapeutic in the autoimmune diseases. Int. Immunopharmacol. 2020;81:106296. doi: 10.1016/j.intimp.2020.106296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106296</ArticleId><ArticleId IdType="pubmed">32058934</ArticleId></ArticleIdList></Reference><Reference><Citation>Petitto JM, McCarthy DB, Rinker CM, Huang Z, Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J. Neuroimmunol. 1997;73(1&#x2013;2):183&#x2013;190. doi: 10.1016/S0165-5728(96)00196-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(96)00196-8</ArticleId><ArticleId IdType="pubmed">9058775</ArticleId></ArticleIdList></Reference><Reference><Citation>Stypu&#x142;a G, Kunert-Radek J, Stepie&#x144; H, Zyli&#x144;ska K, Pawlikowski M. Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with Parkinson&#x2019;s disease. NeuroImmunoModulation. 1996;3(2&#x2013;3):131&#x2013;134. doi: 10.1159/000097237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000097237</ArticleId><ArticleId IdType="pubmed">8945728</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y. Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: A systematic review and meta-analysis. JAMA Neurol. 2016;73(11):1316&#x2013;1324. doi: 10.1001/jamaneurol.2016.2742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.2742</ArticleId><ArticleId IdType="pubmed">27668667</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodacki B, Staszewski J, Toczy&#x142;owska B, Koz&#x142;owska E, Drela N, Chalimoniuk M, Stepien A. Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci. Lett. 2008;441(2):158&#x2013;162. doi: 10.1016/j.neulet.2008.06.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2008.06.040</ArticleId><ArticleId IdType="pubmed">18582534</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalcman SS. Interleukin-2-induced increases in climbing behavior: Inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Res. 2002;944(1&#x2013;2):157&#x2013;164. doi: 10.1016/S0006-8993(02)02740-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(02)02740-3</ArticleId><ArticleId IdType="pubmed">12106675</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry S, Dossou C, Kashif A, Sharifinejad N, Azizi G, Hamedifar H, Sabzvari A, Zian Z. The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases. Int. Immunopharmacol. 2022;102:108402. doi: 10.1016/j.intimp.2021.108402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108402</ArticleId><ArticleId IdType="pubmed">34863654</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, Akg&#xfc;n K, Ziemssen T, Kipp M, G&#xfc;nther R, Hermann A. Interleukin-17 and Th17 lymphocytes directly impair motoneuron survival of wildtype and FUS-ALS mutant human iPSCs. Int. J. Mol. Sci. 2021;22(15):8042. doi: 10.3390/ijms22158042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158042</ArticleId><ArticleId IdType="pmc">PMC8348495</ArticleId><ArticleId IdType="pubmed">34360808</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Hu Y, Cao Z, Liu Q, Cheng Y. Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer&#x2019;s disease, Parkinson's disease and amyotrophic lateral sclerosis: A systematic review and meta-analysis. Front. Immunol. 2018;9:2122. doi: 10.3389/fimmu.2018.02122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02122</ArticleId><ArticleId IdType="pmc">PMC6156158</ArticleId><ArticleId IdType="pubmed">30283455</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa T, Matsui N, Fujita K, Nodera H, Shimizu F, Miyamoto K, Takahashi Y, Kanda T, Kusunoki S, Izumi Y, et al. CSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy. Neurol. Neuroimmunol. Neuroinflamm. 2015;2(5):e138. doi: 10.1212/NXI.0000000000000138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000138</ArticleId><ArticleId IdType="pmc">PMC4529282</ArticleId><ArticleId IdType="pubmed">26280014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M, Rombos A, Nikolaou C, Zoga M, Zouvelou V, Dimitrakopoulos A, Alexakis T, Tsoutsou A, Samakovli A, Michalopoulou M, et al. Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: A reflection of Th17 cells activation? Acta Neurol. Scand. 2010;122(6):425&#x2013;429. doi: 10.1111/j.1600-0404.2010.01333.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2010.01333.x</ArticleId><ArticleId IdType="pubmed">20219021</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelton DL, Reichardt LF. Studies on the regulation of beta-nerve growth factor gene expression in the rat iris: The level of mRNA-encoding nerve growth factor is increased in irises placed in explant cultures in vitro, but not in irises deprived of sensory or sympathetic innervation in vivo. J. Cell Biol. 1986;102(5):1940&#x2013;1948. doi: 10.1083/jcb.102.5.1940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.102.5.1940</ArticleId><ArticleId IdType="pmc">PMC2114227</ArticleId><ArticleId IdType="pubmed">3700478</ArticleId></ArticleIdList></Reference><Reference><Citation>Milonas I. Amyotrophic lateral sclerosis: An introduction. J. Neurol. 1998;245(Suppl 2):S1&#x2013;S3. doi: 10.1007/s004150050640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150050640</ArticleId><ArticleId IdType="pubmed">9747926</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, Steyn FJ, Huang L, Mantovani S, Pfluger CM, Woodruff TM, O'Sullivan JD, Henderson RD, McCombe PA. Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2015;357(1&#x2013;2):22&#x2013;27. doi: 10.1016/j.jns.2015.06.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.06.053</ArticleId><ArticleId IdType="pubmed">26198021</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JT, Dong SQ, Qian T, Yang WB, Chen XJ. Mouse nerve growth factor injection and progression rate in patients with amyotrophic lateral sclerosis: An observational study. Front. Neurol. 2022;13:829569. doi: 10.3389/fneur.2022.829569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.829569</ArticleId><ArticleId IdType="pmc">PMC8891443</ArticleId><ArticleId IdType="pubmed">35250834</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Cassina P, Vargas MR, Castellanos R, Viera L, Beckman JS, Est&#xe9;vez AG, Barbeito L. Astrocytic production of nerve growth factor in motor neuron apoptosis: Implications for amyotrophic lateral sclerosis. J. Neurochem. 2004;89(2):464&#x2013;473. doi: 10.1111/j.1471-4159.2004.02357.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02357.x</ArticleId><ArticleId IdType="pubmed">15056289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito C, Sato H, Ando K, Watanabe S, Yoshiba F, Kishi K, Furuya A, Shitara K, Sugimoto S, Kohno H, et al. Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation. Bone Marrow Transplant. 2003;32(4):391&#x2013;398. doi: 10.1038/sj.bmt.1704152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bmt.1704152</ArticleId><ArticleId IdType="pubmed">12900775</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe Y, Kimura N, Takahashi R, Gotou M, Mizukami K, Uchida H, Matsubara E. Relationship between cytokine levels in the cerebrospinal fluid and 11C-Pittsburgh compound B retention in patients with mild cognitive impairment. Geriatr. Gerontol. Int. 2017;17(11):1907&#x2013;1913. doi: 10.1111/ggi.12991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.12991</ArticleId><ArticleId IdType="pubmed">28261965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukowati C, Patti R, Pascut D, Ladju RB, Tarchi P, Zanotta N, Comar M, Tiribelli C, Croc&#xe8; LS. Serum stem cell growth factor beta for the prediction of therapy response in hepatocellular carcinoma. Biomed. Res. Int. 2018;2018:6435482. doi: 10.1155/2018/6435482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6435482</ArticleId><ArticleId IdType="pmc">PMC6136561</ArticleId><ArticleId IdType="pubmed">30246025</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno E, Cooper RJ, Wilson EL, Gabrilove JL, Hoffman R. Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood. 1993;82(2):430&#x2013;435. doi: 10.1182/blood.V82.2.430.430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V82.2.430.430</ArticleId><ArticleId IdType="pubmed">8329701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogino R, Murayama N, Noshita T, Takemoto N, Toba T, Oka T, Narii N, Yoshida S, Ueno N, Inoue T. SUN11602 has basic fibroblast growth factor-like activity and attenuates neuronal damage and cognitive deficits in a rat model of Alzheimer&#x2019;s disease induced by amyloid &#x3b2; and excitatory amino acids. Brain Res. 2014;1585:159&#x2013;166. doi: 10.1016/j.brainres.2014.08.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.08.023</ArticleId><ArticleId IdType="pubmed">25130662</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopa EG, Gonzalez AM, Chorsky R, Corona RJ, Alvarez J, Bird ED, Baird A. Basic fibroblast growth factor in Alzheimer's disease. Biochem. Biophys. Res. Commun. 1990;171(2):690&#x2013;696. doi: 10.1016/0006-291X(90)91201-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(90)91201-3</ArticleId><ArticleId IdType="pubmed">2403357</ArticleId></ArticleIdList></Reference><Reference><Citation>Siedlak SL, Cras P, Kawai M, Richey P, Perry G. Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. J. Histochem. Cytochem. 1991;39(7):899&#x2013;904. doi: 10.1177/39.7.1865106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/39.7.1865106</ArticleId><ArticleId IdType="pubmed">1865106</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Yang X, Gao L, Zang D. Evaluating the levels of CSF and serum factors in ALS. Brain Behav. 2017;7(3):e637. doi: 10.1002/brb3.637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.637</ArticleId><ArticleId IdType="pmc">PMC5346523</ArticleId><ArticleId IdType="pubmed">28293476</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Z, Gao L, Guo J, Lu Y, Zang D. bFGF in the CSF and serum of sALS patients. Acta Neurol. Scand. 2015;132(3):171&#x2013;178. doi: 10.1111/ane.12381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12381</ArticleId><ArticleId IdType="pubmed">25631037</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh SH, Baik W, Noh MY, Cho GW, Kim HY, Kim KS, Kim SH. The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate. Exp. Neurol. 2012;233(1):472&#x2013;480. doi: 10.1016/j.expneurol.2011.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.11.021</ArticleId><ArticleId IdType="pubmed">22119626</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgadari C, Farber JM, Angiolillo AL, Liao F, Teruya-Feldstein J, Burd PR, Yao L, Gupta G, Kanegane C, Tosato G. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. Blood. 1997;89(8):2635&#x2013;2643. doi: 10.1182/blood.V89.8.2635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V89.8.2635</ArticleId><ArticleId IdType="pubmed">9108380</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker DG, Lue LF, Serrano G, Adler CH, Caviness JN, Sue LI, Beach TG. Altered expression patterns of inflammation-associated and trophic molecules in substantia nigra and striatum brain samples from Parkinson&#x2019;s disease, incidental Lewy body disease and normal control cases. Front. Neurosci. 2015;9:507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4712383</ArticleId><ArticleId IdType="pubmed">26834537</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>